Subthreshold Laser Treatment Versus Threshold Laser Treatment for Symptomatic Retinal Arterial Macroaneurysm
NCT01301326 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2011-02-23
Summary
Best treatment option of retinal arterial macroaneurysm is still controversial. A recent publication has shown that subthreshold laser treatment can be beneficial in improving visual acuity in eyes with symptomatic retinal arterial macroaneurysm. Aim of the study is to compare the effects of subthreshold laser treatment and threshold laser treatment in patients affected by symptomatic retinal arterial macroaneurysm.
Conditions
- Aneurysm
Interventions
- DEVICE
-
subthreshold and threshold laser treatment
subthreshold laser treatment
- DEVICE
-
Threshold laser treatment
threshold laser treatment
Sponsors & Collaborators
-
IRCCS San Raffaele
lead OTHER
Principal Investigators
-
Francesco Bandello, MD · Department of Ophthalmology
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 35 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-04-30
- Primary Completion
- 2011-02-28
- Completion
- 2011-02-28
Countries
- Italy
Study Locations
More Related Trials
-
Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina
NCT02088151 ·Status: TERMINATED ·Phase: NA
-
Safety and Effectiveness Study of 532nm Laser Subthreshold Panretinal Photocoagulation for Severe NPDR
NCT01759121 ·Status: UNKNOWN ·Phase: NA
-
MacTel Laser Study
NCT03321916 ·Status: COMPLETED ·Phase: NA
-
Selective RPE Laser Treatment (SRT) for Various Macular Diseases
NCT00403884 ·Status: UNKNOWN ·Phase: NA
-
"Stop Early Age-related Macular Degeneration (AMD) From Vision Loss Eternally" Study
NCT02960828 ·Status: UNKNOWN ·Phase: NA
-
577nm Micropulse Laser Versus 532nm Subthreshold Laser Photocoagulation for Diabetic Macular Edema
NCT02406157 ·Status: COMPLETED ·Phase: NA
-
Laser (Selective Retina Therapy) and Drug Combined Intervention in Clinically Significant Diabetic Macular Edema
NCT03759860 ·Status: UNKNOWN ·Phase: PHASE4
-
Subtenon Autologous Platelet-Rich Plasma in Inherited and Degenerative Retinal Diseases
NCT07341919 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Non-Damaging Photothermal Therapy of Non-exudative Age Related Macular Degeneration
NCT02569892 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Low-Fluence PRP for PDR
NCT01737957 ·Status: TERMINATED ·Phase: NA
-
Navigation Laser Versus Traditional Laser Photocoagulation for Mild Diabetic Macular Edema
NCT03641144 ·Status: UNKNOWN ·Phase: NA
-
Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration
NCT07266584 ·Status: RECRUITING ·Phase: NA
-
Microneedle Intra-Arterial Injection for Retinal Artery Occlusion
NCT07151755 ·Status: RECRUITING ·Phase: NA
-
Non-damaging Retinal Laser Therapy With PASCAL Laser for Macular Diseases
NCT01975103 ·Status: UNKNOWN ·Phase: PHASE2
-
Sub-threshold Micro-Pulse Laser Therapy for Drusen of Dry AMD
NCT03968575 ·Status: UNKNOWN ·Phase: NA
-
Treatment of Patients With Neovascular AMD Using Indocyanine Green-Mediated Photothrombosis (i-MP).
NCT00331253 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparison of Different Fluence Settings for Yellow Subthreshold Laser Treatment in Diabetic Macular Edema
NCT03571659 ·Status: COMPLETED
-
Micropulse Laser in Treatment of Initial and Refractory Cases of Center-Involved Diabetic Macular Edema
NCT07295704 ·Status: RECRUITING
-
Evaluation of the Effects of Selective Photocoagulation for the Treatment of Diabetic Macular Edema
NCT01355692 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Intravitreal Injection of MSCs in Retinitis Pigmentosa
NCT01531348 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Two Laser Therapy Methods for PDR
NCT01232179 ·Status: UNKNOWN ·Phase: PHASE2
-
Targeted Laser in Diabetic Macular Edema
NCT03751501 ·Status: COMPLETED ·Phase: NA
-
Additional Effect of Subthreshold Micropulse Laser to Intravitreous Injection of Bevacizumab on Diabetic Macular Edema
NCT05582577 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Intravitreal Aflibercept Injection in Vision Impairment Due to DME
NCT01331681 ·Status: COMPLETED ·Phase: PHASE3
-
Early Reperfusion Therapy With Intravenous Thrombolysis for Recovery of VISION in Acute Central Retinal Artery Occlusion
NCT04965038 ·Status: TERMINATED ·Phase: PHASE3